Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease
Data(s) |
01/05/2013
|
---|---|
Resumo |
In Switzerland, the first course of intravenous steroids for treatment of episodes of demyelinating CNS disease is usually administered in an inpatient setting. We prospectively evaluated short term tolerance of treatment with special emphasis on sleep quality. |
Formato |
application/pdf |
Identificador |
http://boris.unibe.ch/15951/1/smw-2013-13783.pdf Lienert, Carmen; Schawalder, Gabriela; Findling, Oliver; Kamm, Christian P.; Humpert, Sebastian; Mugglin, Anne; Mathis, Johannes; Sturzenegger, Matthias; Mattle, Heinrich P. (2013). Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease. Swiss medical weekly, 143, w13783. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2013.13783 <http://dx.doi.org/10.4414/smw.2013.13783> doi:10.7892/boris.15951 info:doi:10.4414/smw.2013.13783 info:pmid:23740464 urn:issn:1424-7860 |
Idioma(s) |
eng |
Publicador |
EMH Schweizerischer Ärzteverlag |
Relação |
http://boris.unibe.ch/15951/ |
Direitos |
info:eu-repo/semantics/openAccess |
Fonte |
Lienert, Carmen; Schawalder, Gabriela; Findling, Oliver; Kamm, Christian P.; Humpert, Sebastian; Mugglin, Anne; Mathis, Johannes; Sturzenegger, Matthias; Mattle, Heinrich P. (2013). Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease. Swiss medical weekly, 143, w13783. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2013.13783 <http://dx.doi.org/10.4414/smw.2013.13783> |
Palavras-Chave | #610 Medicine & health |
Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion PeerReviewed |